Peptide beginner mistakes: what TikTok gets wrong vs. right

What did @maxrfat2fit__ actually say?

The creator laid out three beginner mistakes: confusing syringe unit measurements with actual compound doses, following rigid dosing schedules from the internet, and purchasing peptides without a certificate of analysis. The math lesson is the most substantive part of the video.

On reconstitution, the creator walks through a reasonable example: a 10mg vial reconstituted with 1mL of bacteriostatic water gives you 2mg per 20 units. Add a second mL and now 2mg costs you 40 units. The core point is that "units" on an insulin syringe are meaningless without knowing both the total mass in the vial and the volume of solvent added. That is correct. The creator also recommends an online peptide calculator, which is genuinely useful for avoiding these errors.

On dosing variation, they suggest individual metabolism drives dramatically different responses to the same compound. On COAs, they list purity, sterility, lipopolysaccharide (LPS) content, and heavy metals as things to verify before buying.

Does the science back this up?

The reconstitution math is straightforward pharmacology and checks out completely. The individual variability claim has real biological grounding, though the creator uses it loosely.

Reconstitution calculations are basic dilution chemistry. If you have 10mg in 2mL, you have 5mg/mL, or 0.05mg per unit on a 100-unit insulin syringe. This is not controversial. The confusion between volume and dose is genuinely one of the most common sources of self-administration error documented in harm reduction literature (Brennan et al., 2018, Drug and Alcohol Dependence).

On individual variability, pharmacokinetic differences between people are well established. Genetic polymorphisms in drug-metabolizing enzymes, body composition, and receptor sensitivity all modulate peptide response. However, the creator attributes this entirely to "metabolizing differently" without distinguishing pharmacokinetics from pharmacodynamics, receptor sensitivity, or baseline hormonal status. That is a simplification, but not a wrong one for a beginner audience.

COA requirements for LPS testing are genuinely important. Lipopolysaccharide contamination in injectable peptides can trigger inflammatory responses. ISO 10993 and USP <85> endotoxin testing standards exist precisely because this is a real risk.

What did they get wrong (or right)?

The reconstitution explanation is accurate and the COA checklist is mostly solid. The dosing variability section is vague in ways that could be harmful, and one product reference in the video raises a compliance flag.

What they got right: the unit-to-dose math is correct, the peptide calculator recommendation is practical, and the COA checklist covers the right categories. Requiring batch number traceability and QR code verification is exactly what a quality-minded buyer should do.

What is murkier: the creator says "you can't go off of some certain dosing schedule online" but then implicitly validates a "typical starting dose of 2 milligrams" for what appears to be a semaglutide-adjacent compound. That is itself a dosing reference. The logic undercuts itself.

More concerning: the video closes with a direct link to a peptide vendor, "highcompounds.is," positioned as a source for "research" peptides. Recommending a specific commercial vendor while discussing dosing and administration of injectable compounds is a pattern regulators have scrutinized. Viewers should note the creator has a financial relationship with that vendor.

What should you actually know?

The dosing math lesson is genuinely useful. The COA guidance is directionally correct. But the video skips several things that matter more than unit calculations.

First, none of the peptides referenced in this video category have FDA approval for the uses implied here. BPC-157, TB-500, CJC-1295, and similar compounds are not approved drugs. "Research peptides" sold online exist in a legal and quality gray zone regardless of COA documentation.

Second, a COA from a third-party lab is only as reliable as that lab. Independent verification matters. Look for labs accredited to ISO/IEC 17025 standards, not just any lab the vendor chose to use.

Third, sterility in a reconstituted peptide depends heavily on technique after the vial is opened, not just what the COA says before. Bacteriostatic water, proper needle handling, and storage conditions all affect safety in ways no COA can retroactively guarantee.

• Reconstitution math: always calculate from total mg in vial divided by total mL of solvent added to get mg/mL concentration.
• LPS contamination is a real injectable risk, USP endotoxin limits exist for a reason.
• A COA does not make an unapproved compound medically supervised or legally dispensed.
• The creator sells peptides through the vendor linked in their bio, which is a conflict of interest worth knowing.